Tuesday, August 3, 2010
Drug Trials Have Positive Outcomes when Funded by Drug Maker
In trials funded by non-federal organizations or nonprofits, a positive outcome was reported 72% of the time; among those that received contributions from the drug maker, reviews were more likely to be positive (85%) compared to those without industry support (61%).
This report was published Monday, August 2, 2010 in the Annals of Internal Medicine.
If you or a loved one has been harmed by a dangerous or defective drug anywhere in the United States, please contact the pharmaceutical litigation attorneys at Schlichter, Bogard & Denton today.
posted by
Lynn
at
7:44 AM

<< Home